VIVUS, Inc. (VVUS) Ticks Higher as Arena (ARNA) Pulls BELVIQ MAA in Europe
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
VIVUS (VVUS) to Report Q1 Results May 8th; Focus on Promotions vs. New Rx
May 3, 2013 9:20 AM EDTFollowing Arena Pharmaceutical's (Nasdaq: ARNA) Q1 results and plans to pull its MAA for BELVIQ from Europe (which may... More
Arena Pharmaceuticals (ARNA) Withdraws EU BELVIQ Application
May 2, 2013 4:24 PM EDTArena Pharmaceuticals, Inc. (NASDAQ: ARNA) notified the European Medicines Agency that the company is withdrawing the BELVIQ Marketing Authorization Application (MAA) in the European Union. Arena is currently evaluating the best approach for submitting at a later date.... More
